14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
NOV vs CAM: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
NOV Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 7–3 Matrix Metrics)
NOV Overall Winner
6-Pillar Tally: NOV 6 – 0 CAM
Matrix Metrics: NOV 7 – 3 CAM
As of Nov 20, 2026, NOV Inc. (NOV) is the stronger overall head-to-head candidate over CAM (CAM) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NOV carries a Unified Composite Score of 40.0/100 (SELL) at $16.02 (12.5x Forward P/E, 7.0% operating margin), whereas CAM carries 48.4/100 (HOLD) at $24.55 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While CAM currently prints a higher short-term Unified Composite Score (48.4/100 HOLD vs. NOV 40.0/100 SELL), NOV captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (7.0% vs. N/A operating margin) and revenue trajectory (+2.3% vs. N/A YoY).
Technical & Structure Timing Caution: NOV is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.4); meanwhile CAM trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 52.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NOV vs CAM. Trailing 12-month operating profitability (NOV 7.0% vs CAM N/A) and valuation multiples (NOV 12.5x vs CAM N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ NOV vs CAM Key Questions & Quantitative Answers
As of Nov 20, 2026, NOV Inc. (NOV) is the stronger overall head-to-head candidate over CAM (CAM) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NOV carries a Unified Composite Score of 40.0/100 (SELL) at $16.02 (12.5x Forward P/E, 7.0% operating margin), whereas CAM carries 48.4/100 (HOLD) at $24.55 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While CAM currently prints a higher short-term Unified Composite Score (48.4/100 HOLD vs. NOV 40.0/100 SELL), NOV captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (7.0% vs. N/A operating margin) and revenue trajectory (+2.3% vs. N/A YoY). Technical & Structure Timing Caution: NOV is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.4); meanwhile CAM trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 52.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
NOV leads the Growth & Scale pillar: NOV posts +2.3% YoY revenue growth and +127.3% YoY earnings growth on $8.69B TTM revenue (21.3% gross margin, 7.0% operating margin), compared with CAM at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, NOV generates $8.69B in USD-normalized revenue versus N/A for CAM. In operating R&D and SG&A reinvestment, NOV deploys 14.3% of Rev ($1.24B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CAM.
NOV screens cheaper on headline valuation multiples. NOV trades at 12.5x Forward P/E, 40.2x Trailing P/E, 0.69x PEG, and 0.8x EV/Revenue (3.1% FCF margin), whereas CAM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NOV (2.3% ROE) versus CAM (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, NOV carries 50.7% implied volatility (41st %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.49β · 40% Vol realized risk). By comparison, CAM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.04β · 3% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.